Generated: December 18, 2017
DrugPatentWatch Database Preview
Details for Patent: 6,727,286
« Back to Dashboard
Which drugs does patent 6,727,286 protect, and when does it expire?
Summary for Patent: 6,727,286
|Title:|| Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid|
|Abstract:||The present invention provides a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than 1:1, as well as a method of making the same. The present invention also provides a method of treating a condition chosen from pain, inflammation, fever, and/or other conditions alleviated by ibuprofen comprising administering a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than 1:1.|
|Inventor(s):|| Pavliv; Leo (Morrisville, NC) |
|Assignee:|| Cumberland Pharmaceuticals Inc. (Nashville, TX) |
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Use; |
||Patented / Exclusive Use
|Cumberland Pharms||CALDOLOR||ibuprofen||SOLUTION;INTRAVENOUS||022348-001||Jun 11, 2009||DISCN||No||No||► Subscribe||► Subscribe||Y||MANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN ADJUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITY||► Subscribe|
|Cumberland Pharms||CALDOLOR||ibuprofen||SOLUTION;INTRAVENOUS||022348-002||Jun 11, 2009||RX||Yes||Yes||► Subscribe||► Subscribe||Y||MANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN ADJUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITY||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
International Patent Family for Patent: 6,727,286
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.